| 000 | 01653 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515151047.0 | ||
| 264 | 0 | _c20090309 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1460-9568 | ||
| 024 | 7 |
_a10.1111/j.1460-9568.2008.06491.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Hsin-Mei | |
| 245 | 0 | 0 |
_aA chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. _h[electronic resource] |
| 260 |
_bThe European journal of neuroscience _cNov 2008 |
||
| 300 |
_a2003-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBenzothiazoles _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEukaryotic Initiation Factor-2 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aNerve Degeneration _xdrug therapy |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aeIF-2 Kinase _xantagonists & inhibitors |
| 700 | 1 | _aWang, Lulu | |
| 700 | 1 | _aD'Mello, Santosh R | |
| 773 | 0 |
_tThe European journal of neuroscience _gvol. 28 _gno. 10 _gp. 2003-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2008.06491.x _zAvailable from publisher's website |
| 999 |
_c18501232 _d18501232 |
||